Flavoxate hydrochloride is an antispasmodic medication primarily used to relieve symptoms associated with bladder irritation, such as pain and urgency. It is used to treat various conditions involving the bladder and urinary tract.
Flavoxate hydrochloride is commonly used for:
| Brand Name | Urilax |
|---|---|
| Type | Tablet |
| Weight | 100 mg |
| Generic | Flavoxate Hydrochloride |
| Manufacturer | Incepta Pharmaceuticals Ltd. |
| Available in | English বাংলা |
Flavoxate hydrochloride acts as an antispasmodic agent by inhibiting the smooth muscle contractions of the bladder and urinary tract. It reduces the frequency and intensity of bladder contractions, helping to relieve symptoms associated with bladder spasms and urinary tract irritation.
Flavoxate hydrochloride typically begins to work within 1 to 2 hours after oral administration. Symptomatic relief may be observed within this time frame, with continued improvement over several days of consistent use.
Flavoxate hydrochloride is well-absorbed from the gastrointestinal tract after oral administration. Peak plasma concentrations are usually reached within 1 to 2 hours, allowing for effective symptom management.
Flavoxate hydrochloride is primarily metabolized in the liver. The metabolites and a small portion of the unchanged drug are excreted in the urine. The rate of elimination may be influenced by liver and kidney function.
The standard dosage of flavoxate hydrochloride is:
Dosage adjustments may be necessary based on the severity of symptoms and individual patient response.
Flavoxate hydrochloride is administered orally in the form of tablets. It should be taken with water, and the dosage schedule should be followed consistently. The medication can be taken with or without food.
Common side effects include:
Less common side effects may include allergic reactions or significant changes in blood pressure. Report any severe or persistent symptoms to a healthcare provider.
Symptoms of toxicity may include severe drowsiness, confusion, or rapid heart rate. In case of overdose or severe adverse reactions, seek immediate medical attention for appropriate management.
Precautions include:
Flavoxate hydrochloride may interact with other medications that affect the central nervous system or the liver. Inform healthcare providers of all concurrent medications to avoid potential interactions.
Use with caution in patients with:
Potential drug interactions may occur with other anticholinergic medications or those that affect liver enzymes. Consult a healthcare provider for guidance on potential drug interactions.
Flavoxate hydrochloride can be taken with or without food. There are no specific food interactions; however, it is advisable to follow a balanced diet to maintain overall health while on medication.
Flavoxate hydrochloride is categorized as a pregnancy Category B drug. This indicates that it is not expected to harm an unborn baby based on animal studies, but there are limited human studies. Consult a healthcare provider before using this medication during pregnancy.
It is not known if flavoxate hydrochloride passes into breast milk. Use with caution if breastfeeding, and consult a healthcare provider for alternatives or guidance on safe use during lactation.
In case of acute overdose, symptoms may include severe drowsiness, dizziness, or confusion. Immediate medical attention is required for appropriate management and supportive care.
Flavoxate hydrochloride is contraindicated in individuals with:
Follow the prescribed dosage and administration instructions. Do not exceed the recommended dose. If a dose is missed, take it as soon as possible unless it is almost time for the next dose. Avoid doubling doses to make up for missed ones.
Store flavoxate hydrochloride tablets at room temperature, away from moisture and heat. Keep the medication out of reach of children and in its original packaging to maintain stability.
The volume of distribution for flavoxate hydrochloride is not extensively documented but is generally consistent with other medications that are widely distributed in body tissues after oral administration.
The half-life of flavoxate hydrochloride is approximately 2 to 3 hours. This allows for its effective management of symptoms with frequent dosing.
Flavoxate hydrochloride is cleared from the body primarily through hepatic metabolism and renal excretion. Clearance rates may vary based on individual patient factors such as liver and kidney function.
See in details version Urilax Tablet 100 mg also Urilax Tablet 100 mg in bangla